Sensyne Health (LON:SENS) Trading Down 33.3% – Should You Sell?

Sensyne Health PLC (LON:SENS)’s stock price was down 33.3% during trading on Friday . The company traded as low as GBX 0.16 ($0.00) and last traded at GBX 0.35 ($0.00). Approximately 4,449,142 shares were traded during trading, an increase of 29% from the average daily volume of 3,449,819 shares. The stock had previously closed at GBX 0.53 ($0.01).

Sensyne Health Trading Down 33.3 %

The company has a debt-to-equity ratio of 6.02, a quick ratio of 2.26 and a current ratio of 2.26. The firm has a market capitalization of £582,624.00 and a P/E ratio of -0.02. The firm has a 50 day moving average price of GBX 0.35 and a two-hundred day moving average price of GBX 0.35.

Sensyne Health Company Profile

Sensyne Health plc is a healthcare technology company that creates value from accelerating the discovery and development of new medicines and improving patient care through the analysis of real-world evidence from large databases of anonymised patient data in collaboration with NHS Trusts. These anonymised patient data are ethically sourced in that any analysis of anonymised patient data (and hence the Company’s access to it) must be pre-approved for each programme on a case-by-case basis by the relevant NHS Trusts.